Zymo Research 坚持其创新的 cfDNA 技术以回应 Qiagen 的诉讼

Zymo Research 尊重知识产权,并相信这项技术代表了核酸纯化的重大进步。

来源:None
Zymo Research Corporation是创新生命科学解决方案的领导者,感谢Qiagen Gmbh于2024年8月20日在美国加利福尼亚州中部地区的MagicBead CFDNA隔离技术提起的专利侵权诉讼。 Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.“Our MAGic cfDNA purification system is a groundbreaking innovation," said Dr. Larry Jia, Founder and CEO of Zymo Research. "While this legal challenge places a significant burden on our resources as a small company, our commitment to the scientific community is stronger than ever.”For over 30 years, Zymo Research, a company of “Scientists对于科学家来说,”提供了创新的解决方案,以满足研究人员不断发展的需求。尽管Zymo Research是一家庞大的公司,但Zymo Research提供了遗传,表观遗传学和微生物研究工具的最先进解决方案,再到环保样品运输解决方案。 This is owed to prioritizing a culture of innovation, quality, and customer service.“Our success is rooted in the trust of our customers and researchers worldwide," said Dr. Marc Van Eden, VP of Corporate Development. "We are committed to giving back to the community with the best, most innovative products.”Despite this legal challenge, Zymo Research remains focused on its mission of advancing life science with reliable solutions trusted by thousands of researchers globally and serves as a提醒他们对科学的坚定承诺和人类的改善。

“我们的魔术CFDNA纯化系统是一项开创性的创新,” Zymo Research的创始人兼首席执行官Larry Jia博士说:“尽管这项法律挑战作为小型公司给我们的资源带来了重大负担,但我们对科学界的承诺比以往任何时候都更加强大。”